The Europe Facial Injectable Market is witnessing unprecedented growth, poised to expand significantly from its valuation of approximately USD 2.63 billion in 2022 to an expected USD 10.95 billion by 2035. This represents an impressive compound annual growth rate (CAGR) of 7.80%, highlighting the escalating consumer interest in aesthetic treatments. Notably, the European market is supported by...